Literature DB >> 6317170

Membrane antigen in small cell carcinoma of the lung defined by monoclonal antibody SM1.

S D Bernal, J A Speak.   

Abstract

Mouse myeloma cells were fused with spleen cells from BALB/c mice immunized with a cell line derived from human small cell carcinoma (SCC) of the lung. The cloned hybridoma SM1 produced antibody that was reactive with the surface membrane of SCC cell lines and SCC tumors but not with the membrane of several non-SCC cell lines and tumors. SM1 ascites fluid was used to screen for reactivity of the antibody with other human cancer cell lines, tumor tissues, and normal tissues. SM1 antibody was found to be unreactive with neuroblastoma, adrenal carcinoma, melanoma, and bronchial carcinoid. Reactivity was detected with some breast carcinoma cell lines but not with breast cancer tissue specimens. In the same individual, the antibody was reactive with SCC lung tumor and SCC metastatic to the liver but not with normal tissues, including bronchus, lung parenchyma, liver, kidney, and brain. Human erythrocytes and marrow cells were also unreactive. Since SM1 detects an antigen that is present in greatest amounts on the surface membrane of SCC of the lung, this antibody may be useful in tracing the lineage patterns of human lung cancers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6317170

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis.

Authors:  A T Myklebust; K Beiske; A Pharo; C D Davies; S Aamdal; O Fodstad
Journal:  Br J Cancer Suppl       Date:  1991-06

2.  Enhancement of natural killer function through activation of the T11 E rosette receptor.

Authors:  R E Schmidt; J M Michon; J Woronicz; S F Schlossman; E L Reinherz; J Ritz
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

3.  A monoclonal antibody specific for cells of the melanocyte lineage.

Authors:  C Vennegoor; P Hageman; H Van Nouhuijs; D J Ruiter; J Calafat; P J Ringens; P Rümke
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

4.  Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung.

Authors:  M Mabry; J A Speak; J D Griffin; R A Stahel; S D Bernal
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

5.  A specific and rapid receptor assay for squamous-cell carcinoma of human esophagus.

Authors:  G T Panse; J S Nadkarni; J J Nadkarni
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker.

Authors:  G Moldenhauer; F Momburg; P Möller; R Schwartz; G J Hämmerling
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.